Connor, Clark & Lunn Investment Management (CC&L)’s ALX Oncology ALXO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-83,042
| Closed | -$151K | – | 1400 |
|
|
2024
Q3 | $151K | Buy |
83,042
+56,028
| +207% | +$102K | ﹤0.01% | 1348 |
|
|
2024
Q2 | $163K | Sell |
27,014
-2,070
| -7% | -$12.5K | ﹤0.01% | 1280 |
|
|
2024
Q1 | $324K | Buy |
29,084
+15,775
| +119% | +$176K | ﹤0.01% | 1238 |
|
|
2023
Q4 | $198K | Buy |
+13,309
| New | +$198K | ﹤0.01% | 1264 |
|